Alphamab Oncology files next-day disclosure with HKEX announcing share buyback

PUBT · 4d ago
Alphamab Oncology files next-day disclosure with HKEX announcing share buyback
  • Alphamab Oncology repurchased 312,000 shares for HKD 1.97 million on November 6, 2026.
  • Repurchase prices ranged from HKD 6.22 to HKD 6.38 per share; all repurchased shares will be held as treasury shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261106-12404575), on November 06, 2026, and is solely responsible for the information contained therein.